We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
CME Group (CME) Q2 Earnings Beat, Revenues Decrease Y/Y
Read MoreHide Full Article
CME Group Inc. (CME - Free Report) reported second-quarter 2021 adjusted earnings per share of $1.64, which beat the Zacks Consensus Estimate of $1.59. The bottom line increased 0.6% year over year due to higher market data and information services and lower expenses.
Average daily volume increased in four of the six products lines.
CME Group’s revenues of $1.2 billion decreased 0.3% year over year. The year-over-year decrease was primarily due to lower clearing and transaction fees (down 1.1% year over year) and other (down 3.1%). Increase in market data and information services (up 7.8% year over year) limited the downside. The top line beat the Zacks Consensus Estimate by 0.8%.
Total expenses decreased 7.4% year over year to $504.5 million during the reported quarter, attributable to lower compensation and benefits, professional fees and outside services and amortization of purchased intangibles.
Operating income increased 5.8% from the prior-year quarter to $674.7 million.
Average daily volume improved 5% to 18.4 million driven by double-digit, year-over-year increases in Interest Rates, Agricultural and Options markets. Average rate per contract decreased 4.9%.
Financial Update
As of Jun 30, 2021, CME Group had $1.2 billion of cash and marketable securities, down 31.3% from 2020 end. As of Jun 30, 2021, long-term debt of $3.4 billion remained flat with 2020 end.
As of Jun 30, 2021, the company had total equity worth $26.8 billion, up 1.7% from 2020 end.
Capital Deployment
The company paid out dividends of $322 million in the second quarter. CME Group has returned more than $15.9 billion to shareholders in the form of dividends since the implementation of the variable dividend policy in early 2012.
Performance of Other Securities Exchange Industry Players
Second-quarter earnings of Nasdaq (NDAQ - Free Report) and MarketAxess Holdings (MKTX - Free Report) beat the respective Zacks Consensus Estimate.
Upcoming Release
Cboe Global Markets (CBOE - Free Report) is scheduled to release second-quarter earnings on Jul 30. The Zacks Consensus Estimate for the second quarter is pegged at $1.35.
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
CME Group (CME) Q2 Earnings Beat, Revenues Decrease Y/Y
CME Group Inc. (CME - Free Report) reported second-quarter 2021 adjusted earnings per share of $1.64, which beat the Zacks Consensus Estimate of $1.59. The bottom line increased 0.6% year over year due to higher market data and information services and lower expenses.
Average daily volume increased in four of the six products lines.
CME Group Inc. Price, Consensus and EPS Surprise
CME Group Inc. price-consensus-eps-surprise-chart | CME Group Inc. Quote
Performance in Detail
CME Group’s revenues of $1.2 billion decreased 0.3% year over year. The year-over-year decrease was primarily due to lower clearing and transaction fees (down 1.1% year over year) and other (down 3.1%). Increase in market data and information services (up 7.8% year over year) limited the downside. The top line beat the Zacks Consensus Estimate by 0.8%.
Total expenses decreased 7.4% year over year to $504.5 million during the reported quarter, attributable to lower compensation and benefits, professional fees and outside services and amortization of purchased intangibles.
Operating income increased 5.8% from the prior-year quarter to $674.7 million.
Average daily volume improved 5% to 18.4 million driven by double-digit, year-over-year increases in Interest Rates, Agricultural and Options markets. Average rate per contract decreased 4.9%.
Financial Update
As of Jun 30, 2021, CME Group had $1.2 billion of cash and marketable securities, down 31.3% from 2020 end. As of Jun 30, 2021, long-term debt of $3.4 billion remained flat with 2020 end.
As of Jun 30, 2021, the company had total equity worth $26.8 billion, up 1.7% from 2020 end.
Capital Deployment
The company paid out dividends of $322 million in the second quarter. CME Group has returned more than $15.9 billion to shareholders in the form of dividends since the implementation of the variable dividend policy in early 2012.
Zacks Rank
CME Group currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Performance of Other Securities Exchange Industry Players
Second-quarter earnings of Nasdaq (NDAQ - Free Report) and MarketAxess Holdings (MKTX - Free Report) beat the respective Zacks Consensus Estimate.
Upcoming Release
Cboe Global Markets (CBOE - Free Report) is scheduled to release second-quarter earnings on Jul 30. The Zacks Consensus Estimate for the second quarter is pegged at $1.35.